JTM

official impact factor 3.51

Open Access

Potency analysis of cellular therapies: the emerging role of molecular assays

David F Stroncek*, Ping Jin, Ena Wang and Betsy Jett

Journal of Translational Medicine 2007, 5:24 doi:10.1186/1479-5876-5-24

Accesses  

  • Last 30 days: 73 accesses
  • Last 365 days: 749 accesses
  • All time: 4006 accesses

Cited by

BioMed Central: 2 citations

Commentary   Open Access Highly Accessed

Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology

Hideaki Tahara, Marimo Sato, Magdalena Thurin, Ena Wang, Lisa H Butterfield, Mary L Disis, Bernard A Fox, Peter P Lee, Samir N Khleif, Jon M Wigginton, Stefan Ambs, Yasunori Akutsu, Damien Chaussabel, Yuichiro Doki, Oleg Eremin, Wolf Fridman, Yoshihiko Hirohashi, Kohzoh Imai, James Jacobson, Masahisa Jinushi, Akira Kanamoto, Mohammed Kashani-Sabet, Kazunori Kato, Yutaka Kawakami, John M Kirkwood, Thomas O Kleen, Paul V Lehmann, Lance Liotta, Michael T Lotze, Michele Maio et al. Journal of Translational Medicine 2009, 7:45 (17 June 2009)

Commentary   Open Access

A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"

Lisa H Butterfield, Mary L Disis, Bernard A Fox, Peter P Lee, Samir N Khleif, Magdalena Thurin, Giorgio Trinchieri, Ena Wang, Jon Wigginton, Damien Chaussabel, George Coukos, Madhav Dhodapkar, Leif HÃ¥kansson, Sylvia Janetzki, Thomas O Kleen, John M Kirkwood, Cristina Maccalli, Holden Maecker, Michele Maio, Anatoli Malyguine, Giuseppe Masucci, A Karolina Palucka, Douglas M Potter, Antoni Ribas, Licia Rivoltini, Dolores Schendel, Barbara Seliger, Senthamil Selvan, Craig L Slingluff, David F Stroncek et al. Journal of Translational Medicine 2008, 6:81 (23 December 2008)